Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)

SHA:688506 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	130,526	76,884	56,100	-	-	-
Market Cap Growth	37.05%	37.05%	-	-	-	-
Enterprise Value	126,841	73,458	56,019	-	-	-
Last Close Price	325.50	191.73	139.90	-	-	-
PE Ratio	35.19	20.74	-	-	-	-
Forward PE	1977.66	71.91	-	-	-	-
PS Ratio	22.42	13.20	99.85	-	-	-
PB Ratio	33.59	19.79	369.39	-	-	-
P/TBV Ratio	33.82	19.92	452.87	-	-	-
P/FCF Ratio	32.84	19.34	-	-	-	-
P/OCF Ratio	32.16	18.94	-	-	-	-
EV/Sales Ratio	21.78	12.62	99.70	-	-	-
EV/EBITDA Ratio	33.68	19.57	-	-	-	-
EV/EBIT Ratio	34.41	19.93	-	-	-	-
EV/FCF Ratio	31.91	18.48	-	-	-	-
Debt / Equity Ratio	0.53	0.53	4.48	0.59	0.87	0.33
Debt / EBITDA Ratio	0.55	0.55	-	-	-	5.68
Debt / FCF Ratio	0.52	0.52	-	-	-	2.38
Asset Turnover	1.36	1.36	0.33	0.48	0.80	0.95
Inventory Turnover	1.87	1.87	2.00	2.59	2.75	2.82
Quick Ratio	2.99	2.99	0.52	1.73	0.62	0.89
Current Ratio	3.19	3.19	0.74	1.94	0.90	1.07
Return on Equity (ROE)	183.64%	183.64%	-143.77%	-44.62%	-25.51%	8.62%
Return on Assets (ROA)	53.82%	53.82%	-28.74%	-14.01%	-10.00%	-1.34%
Return on Capital (ROIC)	67.89%	67.89%	-42.44%	-19.63%	-16.33%	-2.33%
Return on Capital Employed (ROCE)	71.50%	71.50%	-	-	-	-
Earnings Yield	2.84%	4.82%	-1.39%	-	-	-
FCF Yield	3.05%	5.17%	-1.24%	-	-	-
Payout Ratio	1.03%	1.03%	-	-	-	26.28%
Buyback Yield / Dilution	-0.14%	-0.14%	-10.56%	-1.38%	-3.64%	10.86%
Total Shareholder Return	-	-0.14%	-10.56%	-1.38%	-3.64%	10.86%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.